We are live on
!
Find out more
ASC
Atalanta Sosnoff Capital Portfolio holdings
AUM
$5.68B
1-Year Est. Return
54.21%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+54.21%
3 Year Est. Return
+205.88%
5 Year Est. Return
+308.89%
10 Year Est. Return
+1,480.72%
AUM
$2.81B
AUM Growth
-$76.7M
(-2.7%)
Cap. Flow
-$213M
Cap. Flow
% of AUM
-7.56%
Top 10 Holdings %
Top 10 Hldgs %
33.27%
Holding
115
New
9
Increased
38
Reduced
54
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$37.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.4M |
| 3 |
Martin Marietta Materials
MLM
|
+$26.5M |
| 4 |
EA
Electronic Arts
EA
|
+$26.3M |
| 5 |
Zoetis
ZTS
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$45.3M |
| 2 |
American Tower
AMT
|
+$43.3M |
| 3 |
AGN
Allergan plc
AGN
|
+$38.7M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$34.8M |
| 5 |
Honeywell
HON
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.45% |
| 2 | Communication Services | 17.7% |
| 3 | Technology | 12.61% |
| 4 | Healthcare | 11.89% |
| 5 | Industrials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
101
DELISTED
Alexion Pharmaceuticals
ALXN
| $203K | 0.01% |
1,660
-20
| -1% | -$2.45K |
|
|
FLG
102
Flagstar Bank National Association
FLG
$5.68B
| $185K | 0.01% |
+3,870
| New | +$177K |
|
103
American Express
AXP
$230B
| – | – |
-10,395
| Closed | -$666K |
|
104
Booking.com
BKNG
$160B
| – | – |
-94,575
| Closed | -$5.57M |
|
105
BP
BP
$113B
| – | – |
-51,468
| Closed | -$1.52M |
|
106
Crown Castle
CCI
$31.8B
| – | – |
-249,283
| Closed | -$23.5M |
|
107
Duke Energy
DUK
$96.4B
| – | – |
-233,056
| Closed | -$18.7M |
|
108
Kroger
KR
$34.5B
| – | – |
-33,770
| Closed | -$1M |
|
109
Medtronic
MDT
$120B
| – | – |
-337,307
| Closed | -$29.1M |
|
110
MetLife
MET
$60.4B
| – | – |
-14,945
| Closed | -$592K |
|
111
Constellation Brands
STZ
$22.8B
| – | – |
-49,665
| Closed | -$8.27M |
|
112
Travel + Leisure Co
TNL
$4.47B
| – | – |
-99,325
| Closed | -$3.02M |
|
|
113
Zimmer Biomet
ZBH
$19.2B
| – | – |
-358,530
| Closed | -$45.3M |
|
|
AGN
114
DELISTED
Allergan plc
AGN
| – | – |
-168,108
| Closed | -$38.7M |
|
|
RAI
115
DELISTED
Reynolds American Inc
RAI
| – | – |
-738,436
| Closed | -$34.8M |
|
Similar funds
SPPAM
BCM
CIA
JCM
ECM
BPWM
KKRC
DSC
Atalanta Sosnoff Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Atalanta Sosnoff Capital held 115 positions worth $2.81B, down 2.7% from $2.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Atalanta Sosnoff Capital withdrew a net $213M in Q4 2016, closing 13 positions and reducing 54 holdings. Its most notable exit was Zimmer Biomet, an estimated $45.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Atalanta Sosnoff Capital opened a new position in Bristol-Myers Squibb worth $30.4M.
- Atalanta Sosnoff Capital's largest Q4 2016 buy was Bristol-Myers Squibb: 520,169 shares worth $30.4M.
- Atalanta Sosnoff Capital added most to Chevron in Q4 2016, an estimated $37.9M increase.
- Atalanta Sosnoff Capital's biggest Q4 2016 reduction was American Tower, cutting an estimated $43.3M.
- Atalanta Sosnoff Capital fully exited Zimmer Biomet in Q4 2016, selling an estimated $45.3M.
- Atalanta Sosnoff Capital's ten largest holdings make up 33% of its $2.81B portfolio in Q4 2016.
- Atalanta Sosnoff Capital opened 9 new positions and closed 13 in Q4 2016.
- Atalanta Sosnoff Capital's portfolio value fell 2.7% quarter-over-quarter to $2.81B.
Based on Atalanta Sosnoff Capital's 13F filing for Q4 2016, filed 10 Jan 2017.